200 related articles for article (PubMed ID: 32368972)
21. Genetic Polymorphism of Thiopurine S-methyltransferase in Children with Acute Lymphoblastic Leukemia in Jordan.
Alsous M; Yousef AM; Abdel Jalil M; Zawiah M; Yacoub S; Momani D; Gharabli A; Omar S; Rihani R
Asian Pac J Cancer Prev; 2018 Jan; 19(1):199-205. PubMed ID: 29373914
[TBL] [Abstract][Full Text] [Related]
22. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
[TBL] [Abstract][Full Text] [Related]
23. Genetic polymorphisms in very important pharmacogenomic (VIP) variants in the Tibetan population.
Jin TB; Xun XJ; Shi XG; Yuan DY; Feng T; Geng TT; Kang LL
Genet Mol Res; 2015 Oct; 14(4):12497-504. PubMed ID: 26505400
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation].
Mirzaev KB; Fedorinov DS; Akmalova KA; Abdullaev SP; Kachanova AA; Sozaeva ZA; Grishina EA; Shuev GN; Kitaeva EY; Shprakh VV; Suleymanov SS; Bolieva LZ; Sozaeva MS; Zhuchkova SM; Gimaldinova NE; Sidukova EE; Burashnikova IS; Shikaleva AA; Zabudskaya KG; Sychev DA
Ter Arkh; 2020 Sep; 92(8):43-51. PubMed ID: 33346461
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms of pharmacogenomic VIP variants in Li nationality of southern China.
Ding Y; He P; He N; Li Q; Sun J; Yao J; Yi S; Xu H; Wu D; Wang X; Jin T
Environ Toxicol Pharmacol; 2016 Mar; 42():237-42. PubMed ID: 26901752
[TBL] [Abstract][Full Text] [Related]
26. Variability of CYP2C8 Polymorphisms in Three Jordanian Populations: Circassians, Chechens and Jordanian-Arabs.
Abudahab S; Hakooz N; Tobeh N; Gogazeh E; Gharaibeh M; Al-Eitan L; Zihlif M; Dajani R
J Immigr Minor Health; 2022 Oct; 24(5):1167-1176. PubMed ID: 34448113
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of pharmacogenomic VIP variants in the Kyrgyz population from northwest China.
Yunus Z; Liu L; Wang H; Zhang L; Li X; Geng T; Kang L; Jin T; Chen C
Gene; 2013 Oct; 529(1):88-93. PubMed ID: 23954225
[TBL] [Abstract][Full Text] [Related]
28. Genetic polymorphisms study of pharmacogenomic VIP variants in Han ethnic of China's Shaanxi province.
Jin T; Zhao R; Shi X; He N; He X; Ouyang Y; Wang H; Wang B; Kang L; Yuan D
Environ Toxicol Pharmacol; 2016 Sep; 46():27-35. PubMed ID: 27414743
[TBL] [Abstract][Full Text] [Related]
29. The landscape of very important pharmacogenes variants and potential clinical relevance in the Chinese Jingpo population: a comparative study with worldwide populations.
Ma X; Li Y; Zang X; Guo J; Zhou W; Han J; Liang J; Wan P; Yang H; Jin T
Cancer Chemother Pharmacol; 2024 May; 93(5):481-496. PubMed ID: 38300251
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort.
Melin K; Moon JY; Qi Q; Hernandez-Suarez DF; Duconge J; Hua S; Gonzalez S; Zeng D; Kaplan RC
Pharmacogenomics; 2019 Jan; 20(2):75-83. PubMed ID: 30520344
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomic assessment of Mexican and Peruvian populations.
Marsh S; King CR; Van Booven DJ; Revollo JY; Gilman RH; McLeod HL
Pharmacogenomics; 2015; 16(5):441-8. PubMed ID: 25916516
[TBL] [Abstract][Full Text] [Related]
32. Genetic polymorphisms of pharmacogenomic VIP variants in the Lisu population of southwestern China: A cohort study.
Li B; Wang L; Lei L; Zhang M; Niu F; Chen P; Jin T
Medicine (Baltimore); 2018 Sep; 97(38):e12231. PubMed ID: 30235667
[TBL] [Abstract][Full Text] [Related]
33. Genetic polymorphisms of pharmacogenomic VIP variants in the Lahu population from Yunnan Province.
Dou X; Yang S; Zhang W; Meng W; Zhao W; Hao J; Hu X; Guo L; Jin T
Gene; 2022 Nov; 844():146825. PubMed ID: 35995116
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphisms of pharmacogenomic VIP variants in the Uygur population from northwestern China.
Wang L; Aikemu A; Yibulayin A; Du S; Geng T; Wang B; Zhang Y; Jin T; Yang J
BMC Genet; 2015 Jun; 16():66. PubMed ID: 26091847
[TBL] [Abstract][Full Text] [Related]
35. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2003 Jun; 55(6):560-9. PubMed ID: 12814450
[TBL] [Abstract][Full Text] [Related]
36. Frequency of MDR1 single nucleotide polymorphisms in a Jordanian population, including a novel variant.
Khabour OF; Alzoubi KH; Al-Azzam SI; Mhaidat NM
Genet Mol Res; 2013 Mar; 12(1):801-8. PubMed ID: 23546964
[TBL] [Abstract][Full Text] [Related]
37. Effects of ABCB1 gene polymorphisms on autonomic nervous system activity during atypical antipsychotic treatment in schizophrenia.
Hattori S; Suda A; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Taguri M; Hirayasu Y
BMC Psychiatry; 2018 Jul; 18(1):231. PubMed ID: 30016952
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of CFTR mutations in Chechen cystic fibrosis patients: high frequency of c.1545_1546delTA (p.Tyr515X; 1677delTA) and c.274G>A (p.Glu92Lys, E92K) mutations in North Caucasus.
Petrova NV; Kashirskaya NY; Saydaeva DK; Polyakov AV; Adyan TA; Simonova OI; Gorinova YV; Kondratyeva EI; Sherman VD; Novoselova OG; Vasilyeva TA; Marakhonov AV; Macek M; Ginter EK; Zinchenko RA
BMC Med Genet; 2019 Mar; 20(1):44. PubMed ID: 30898088
[TBL] [Abstract][Full Text] [Related]
39. The low frequency of defective TPMT alleles in Turkish population: a study on pediatric patients with acute lymphoblastic leukemia.
Tumer TB; Ulusoy G; Adali O; Sahin G; Gozdasoglu S; Arinç E
Am J Hematol; 2007 Oct; 82(10):906-10. PubMed ID: 17617792
[TBL] [Abstract][Full Text] [Related]
40. Genotyping NUDT15*3 rs1166855232 reveals higher frequency of potential adverse effects of thiopurines in Natives and Mestizos from Mexico.
Texis T; Guzmán-Cruz C; Rodríguez-Dorantes M; Sánchez-García S; Mino-León D; Gonzalez-Covarrubias V
Pharmacol Rep; 2022 Feb; 74(1):257-262. PubMed ID: 34091879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
